Fecal transplant for multidrug-resistant bacteria
Treatments studied
Part of Digestive system, Infections clinical trials.
This trial tests whether a fecal microbiota transplant (transferring healthy bacteria from a donor) can help clear multidrug-resistant bacteria from your body. It may be an option if you have such bacteria and are looking for a way to remove them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a positive test from a rectal swab showing multidrug-resistant bacteria.
- You must be able to give your written consent to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests whether a fecal microbiota transplant (FMT) can eliminate hard-to-treat bacteria in the gut, such as ESBL or carbapenem-resistant bacteria. If it works, it may reduce future infections and antibiotic-resistant illness.
This trial tests whether taking capsules containing processed healthy donor stool (fecal microbiota transplant) can safely remove certain drug-resistant bacteria (like CRE, ESBL-E, and VRE) from your intestines. It may be an option for people who have these bacteria in their stool but are not currently being treated with antibiotics.
This trial looks at a treatment made from stool donors (called fecal microbiome therapy) to help remove carbapenem-resistant gut bacteria in the body. It’s mainly for adults who recently tested positive for these bacteria on a rectal swab, and it checks whether the therapy can help eradicate the germs.
This study tests whether a fecal transplant (FMT) can remove certain antibiotic-resistant bacteria from your gut. It might help people who carry superbugs like CPE or VRE but aren't currently on antibiotics.
This study tests a stool-based treatment (fecal microbiota treatment) to help remove “carbapenem-resistant” bacteria living in the gut. If you carry these bacteria without being sick, the goal is to reduce or stop that colonization.
This trial tests whether a treatment called fecal microbiota transplantation (giving you a capsule of healthy bacteria from a donor) can help clear a hard-to-treat bacteria called CRE from your body. It may help prevent future infections and reduce the need for strong antibiotics.
Hear when a new Carbapenem-Resistant Enterobacteriaceae Colonization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.